Sojourn Side Effects

Generic Name: sevoflurane

Note: This document contains side effect information about sevoflurane. Some of the dosage forms listed on this page may not apply to the brand name Sojourn.

In Summary

More frequent side effects include: tachycardia. See below for a comprehensive list of adverse effects.

For the Consumer

Applies to sevoflurane: inhalation liquid

Along with its needed effects, sevoflurane (the active ingredient contained in Sojourn) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention. While you are receiving and recovering from an inhalation anesthetic like sevoflurane, your health care professional will closely follow its effects. However, some effects may not be noticed until later.

Some side effects of sevoflurane may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

• Cough
• dizziness
• drowsiness
• increased amount of saliva
• nausea
• shivering
• vomiting

• Headache

For Healthcare Professionals

Applies to sevoflurane: inhalation liquid

General

The most common adverse events were nausea, vomiting, hypotension, agitation, and cough.^[Ref]

Gastrointestinal

Very common (10% or more): Nausea (25%), vomiting (18%)
Common (1% to 10%): Increased salivation
Uncommon (0.1% to 1%): Dry mouth^[Ref]

Cardiovascular

Very common (10% or more): Hypotension (11%), bradycardia
Common (1% to 10%): Tachycardia, hypertension
Uncommon (0.1% to 1%): Arrhythmia, ventricular extrasystoles, supraventricular extrasystoles, complete AV block, bigeminy, inverted T wave, atrial fibrillation, atrial arrhythmia, second degree AV block, S-T depressed, extrasystoles
Frequency not reported: QT prolongation, torsade de pointes
Postmarketing reports: Cardiac arrest^[Ref]

Respiratory

Very common (10% or more): Cough increased (11%),
Common (1% to 10%): Laryngospasm, airway obstruction, breath holding, apnea, respiratory disorder
Uncommon (0.1% to 1%): Sputum increased, hypoxia, wheezing, bronchospasm, hyperventilation, pharyngitis, hiccup, hypoventilation, dyspnea, stridor, hypoxia, asthma
Postmarketing reports: Pulmonary edema^[Ref]

Psychiatric

Very common (10% or more): Agitation (up to 15%)
Uncommon (0.1% to 1%): Crying, nervousness, confusion, insomnia, confusional state^[Ref]

Nervous system

Common (1% to 10%): Somnolence, dizziness, movement
Uncommon (0.1% to 1%): Syncope, hypertonia, taste perversion
Postmarketing reports: Seizures, dystonia^[Ref]

Other

Common (1% to 10%): Shivering, fever, hypothermia, headache, blood fluoride increased
Uncommon (0.1% to 1%): Asthenia, pain, fluorosis,
Rare (less than 0.1%): Malignant hyperthermia^[Ref]

Hematologic

Common (1% to 10%): White blood cell count abnormal
Uncommon (0.1% to 1%): Hemorrhage, leukocytosis, thrombocytopenia, leukopenia
Postmarketing reports: Transient elevations in white blood cell count^[Ref]

Hepatic

Common (1% to 10%): Liver function test abnormal
Uncommon (0.1% to 1%): Increases in AST, increases in ALT, bilirubinemia
Postmarketing reports: Hepatic dysfunction, hepatitis, jaundice, hepatic necrosis, hepatic failure, transient elevations in liver function tests^[Ref]

Metabolic

Common (1% to 10%): Blood glucose abnormal
Uncommon (0.1% to 1%): Increases in LDH, increases in alkaline phosphatase, hypophosphatemia, acidosis, hyperglycemia
Postmarketing reports: Transient elevations in glucose^[Ref]

Renal

Uncommon (0.1% to 1%): Increases in BUN, increases in creatinine, glycosuria, albuminuria,
Frequency not reported: Mild impairment of renal concentrating ability
Postmarketing reports: Acute renal failure^[Ref]

Ocular

Uncommon (0.1% to 1%): Amblyopia, conjunctivitis^[Ref]

Genitourinary

Uncommon (0.1% to 1%): Urination impaired, urine abnormality, urinary retention, oliguria^[Ref]

Dermatologic

Uncommon (0.1% to 1%): Pruritus, rash^[Ref]

Hypersensitivity

Postmarketing reports: Allergic reactions, urticaria, bronchospasm, anaphylactic or anaphylactoid reaction, hypersensitivity (including contact dermatitis, rash, dyspnea, wheezing, chest discomfort, swelling face, or anaphylactic reaction)^[Ref]

Musculoskeletal

Postmarketing reports: Muscle twitching^[Ref]

Some side effects of Sojourn may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.